Showing results (161-170 of 223) with videos related to

Sort By:
Pageof 23
Molecular Therapy. Methods & Clinical Development|September 2, 2025
FAP-CAR-T cells reduce dystrophic muscle fibrosis, improving adeno-associated virus gene transfer efficacyMaxime Ferrand, Céline J Rocca, Guillaume Corre, et al.
Presse Medicale (Paris, France : 1983)|February 17, 2012
[Assessment of scientific production after initial medical education at the Faculty of Medicine of Angers from 2002 to 2008]Christophe Baufreton, Jean-Marie Chrétien, Florence Moreau-Cordier, et al.
Molecular Therapy. Methods & Clinical Development|October 26, 2019
Role of Regulatory T Cell and Effector T Cell Exhaustion in Liver-Mediated Transgene Tolerance in MuscleJérôme Poupiot, Helena Costa Verdera, Romain Hardet, et al.
Diabetes|May 28, 2005
Type A insulin resistance syndrome revealing a novel lamin A mutationJacques Young, Louise Morbois-Trabut, Béatrice Couzinet, et al.
Human Molecular Genetics|January 20, 2018
Repairing folding-defective α-sarcoglycan mutants by CFTR correctors, a potential therapy for limb-girdle muscular dystrophy 2DMarcello Carotti, Justine Marsolier, Michela Soardi, et al.
International Journal of Cell Biology|March 20, 2010
Alteration of sarcoplasmic reticulum ca release in skeletal muscle from calpain 3-deficient miceGovindan Dayanithi, Isabelle Richard, Cédric Viero, et al.
Journal of Neuromuscular Diseases|October 11, 2021
Anoctamin 5 Knockout Mouse Model Recapitulates LGMD2L Muscle Pathology and Offers Insight Into in vivo Functional DeficitsGirija Thiruvengadam, Sen Chandra Sreetama, Karine Charton, et al.
Biological & Pharmaceutical Bulletin|December 4, 2004
Short term Caco-2/TC7 cell culture: comparison between conventional 21-d and a commercially available 3-d systemGeorges Da Violante, Naima Zerrouk, Isabelle Richard, et al.
European Journal of Pediatrics|January 18, 2006
Calpain-3 mutations in TurkeyBurcu Balci, Stefania Aurino, Göknur Haliloglu, et al.
Brain : a Journal of Neurology|October 31, 2022
Imbalance of NRG1-ERBB2/3 signalling underlies altered myelination in Charcot-Marie-Tooth disease 4HLara El-Bazzal, Adeline Ghata, Clothilde Estève, et al.
Pageof 23